Evidence map

ArticleEndocrinology, diabetes & metabolism2019

Exercise and the dipeptidyl-peptidase IV inhibitor sitagliptin do not improve beta-cell function and glucose homeostasis in long-lasting type 1 diabetes-A randomised open-label study.

Eleonora Seelig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31294088